Page last updated: 2024-10-22

albuterol and Polycystic Ovary Syndrome

albuterol has been researched along with Polycystic Ovary Syndrome in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajendran, S1
Willoughby, SR1
Chan, WP1
Liberts, EA1
Heresztyn, T1
Saha, M1
Marber, MS1
Norman, RJ1
Horowitz, JD1

Other Studies

1 other study available for albuterol and Polycystic Ovary Syndrome

ArticleYear
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
    Atherosclerosis, 2009, Volume: 204, Issue:2

    Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Stud

2009